Acadia Pharmaceuticals | Umsatzkosten



Cost Of Sales Veränderung Datum
Acadia Pharmaceuticals USD 20.39M 1.41M 2025-03
ALKERMES USD 49.46M 263K 2025-06
Alnylam Pharmaceuticals USD 142.95M 71.91M 2025-06
Biogen USD 605M 24.3M 2025-06
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Bristol-Myers Squibb USD 3.37B 339M 2025-06
Corcept Therapeutics USD 2.4M 553K 2025-03
Cytokinetics 463K 79.14M 2024-09
Eisai JPY 40.6B 5.33B 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
Incyte USD 78.77M 10.96M 2025-06
J&J USD 7.6B 304M 2025-06
Moderna USD 90M 456M 2025-03
Neurocrine Biosciences USD 11.3M 2.1M 2025-06
Pfizer USD 2.59B 3.06B 2025-03
Prothena 970K 4.78M 2024-09
PTC Therapeutics USD 12.86M 3.42M 2025-03
Sarepta Therapeutics USD 137.56M 5.26M 2025-03
Ultragenyx Pharmaceutical USD 28.66M 11.77M 2025-03
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12


Acadia Pharmaceuticals Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.